rs75168694

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000334.4(SCN4A):​c.1453-23C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0231 in 1,580,630 control chromosomes in the GnomAD database, including 604 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.020 ( 64 hom., cov: 33)
Exomes 𝑓: 0.023 ( 540 hom. )

Consequence

SCN4A
NM_000334.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0100

Publications

1 publications found
Variant links:
Genes affected
SCN4A (HGNC:10591): (sodium voltage-gated channel alpha subunit 4) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. It is expressed in skeletal muscle, and mutations in this gene have been linked to several myotonia and periodic paralysis disorders. [provided by RefSeq, Jul 2008]
SCN4A Gene-Disease associations (from GenCC):
  • hyperkalemic periodic paralysis
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Orphanet
  • paramyotonia congenita of Von Eulenburg
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Laboratory for Molecular Medicine
  • SCN4A-related myopathy, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, ClinGen, PanelApp Australia
  • hypokalemic periodic paralysis, type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • potassium-aggravated myotonia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome 16
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital myopathy
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital myopathy 22A, classic
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • acetazolamide-responsive myotonia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myotonia fluctuans
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myotonia permanens
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 0 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 17-63963848-G-A is Benign according to our data. Variant chr17-63963848-G-A is described in ClinVar as Benign. ClinVar VariationId is 255844.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0201 (3066/152356) while in subpopulation NFE AF = 0.0318 (2162/68038). AF 95% confidence interval is 0.0307. There are 64 homozygotes in GnomAd4. There are 1511 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 64 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000334.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN4A
NM_000334.4
MANE Select
c.1453-23C>T
intron
N/ANP_000325.4P35499

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN4A
ENST00000435607.3
TSL:1 MANE Select
c.1453-23C>T
intron
N/AENSP00000396320.1P35499

Frequencies

GnomAD3 genomes
AF:
0.0201
AC:
3065
AN:
152238
Hom.:
64
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00354
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00530
Gnomad ASJ
AF:
0.0274
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.0510
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0318
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.0208
AC:
4139
AN:
198914
AF XY:
0.0206
show subpopulations
Gnomad AFR exome
AF:
0.00300
Gnomad AMR exome
AF:
0.00373
Gnomad ASJ exome
AF:
0.0253
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0581
Gnomad NFE exome
AF:
0.0304
Gnomad OTH exome
AF:
0.0180
GnomAD4 exome
AF:
0.0235
AC:
33500
AN:
1428274
Hom.:
540
Cov.:
34
AF XY:
0.0233
AC XY:
16505
AN XY:
707620
show subpopulations
African (AFR)
AF:
0.00257
AC:
84
AN:
32702
American (AMR)
AF:
0.00392
AC:
161
AN:
41062
Ashkenazi Jewish (ASJ)
AF:
0.0244
AC:
622
AN:
25486
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38096
South Asian (SAS)
AF:
0.00192
AC:
157
AN:
81622
European-Finnish (FIN)
AF:
0.0548
AC:
2705
AN:
49322
Middle Eastern (MID)
AF:
0.00210
AC:
12
AN:
5702
European-Non Finnish (NFE)
AF:
0.0262
AC:
28664
AN:
1095166
Other (OTH)
AF:
0.0185
AC:
1095
AN:
59116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
1371
2742
4114
5485
6856
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
954
1908
2862
3816
4770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0201
AC:
3066
AN:
152356
Hom.:
64
Cov.:
33
AF XY:
0.0203
AC XY:
1511
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.00353
AC:
147
AN:
41590
American (AMR)
AF:
0.00529
AC:
81
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0274
AC:
95
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4830
European-Finnish (FIN)
AF:
0.0510
AC:
542
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0318
AC:
2162
AN:
68038
Other (OTH)
AF:
0.0128
AC:
27
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
156
313
469
626
782
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0333
Hom.:
48
Bravo
AF:
0.0145
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.5
DANN
Benign
0.24
PhyloP100
-0.010
BranchPoint Hunter
0.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75168694; hg19: chr17-62041208; API